3-iodobenzylguanidine has been researched along with valine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ichikawa, S; Kasama, S; Kumakura, H; Kurabayashi, M; Suzuki, T; Takayama, Y; Toyama, T | 1 |
| Hatori, T; Ichikawa, S; Kasama, S; Kumakura, H; Kurabayashi, M; Sumino, H; Suzuki, T; Takayama, Y; Toyama, T | 1 |
| Daimon, M; Fujita, M; Komuro, I; Kuwabara, Y; Mizuma, H; Nakayama, K; Narumi, H; Shindo, S | 1 |
| Ikeda, T; Ikeda, Y; Iwasa, K; Kayano, D; Komatsu, J; Nakamura, K; Ono, K; Sakai, K; Samuraki, M; Shibata, S; Takahashi, R; Yamada, M | 1 |
| Hashizume, A; Iijima, M; Ikeda, S; Katsuno, M; Kawagashira, Y; Koike, H; Nakamura, T; Nishi, R; Sobue, G | 1 |
3 trial(s) available for 3-iodobenzylguanidine and valine
| Article | Year |
|---|---|
Addition of valsartan to an angiotensin-converting enzyme inhibitor improves cardiac sympathetic nerve activity and left ventricular function in patients with congestive heart failure.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Drug Synergism; Drug Therapy, Combination; Female; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Stroke Volume; Sympathetic Nervous System; Tetrazoles; Treatment Outcome; Ultrasonography; Valine; Valsartan; Ventricular Dysfunction, Left | 2003 |
Comparative effects of valsartan and enalapril on cardiac sympathetic nerve activity and plasma brain natriuretic peptide in patients with congestive heart failure.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Enalapril; Female; Heart; Heart Failure; Humans; Male; Mediastinum; Middle Aged; Natriuretic Peptide, Brain; Observer Variation; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Tetrazoles; Valine; Valsartan | 2006 |
Valsartan Amlodipine Randomized Trial (VART): design, methods, and preliminary results.
Topics: 3-Iodobenzylguanidine; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Calcium Channel Blockers; Data Interpretation, Statistical; Endpoint Determination; Female; Follow-Up Studies; Humans; Hypertension; Informed Consent; Male; Middle Aged; Patient Selection; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Research Design; Risk Factors; Sample Size; Tetrazoles; Ultrasonography; Valine; Valsartan | 2008 |
2 other study(ies) available for 3-iodobenzylguanidine and valine
| Article | Year |
|---|---|
Efficacy of diflunisal on autonomic dysfunction of late-onset familial amyloid polyneuropathy (TTR Val30Met) in a Japanese endemic area.
Topics: 3-Iodobenzylguanidine; Aged; Amyloid Neuropathies, Familial; Anti-Inflammatory Agents, Non-Steroidal; Autonomic Nervous System Diseases; Diflunisal; Electrocardiography; Female; Humans; Japan; Male; Methionine; Middle Aged; Mutation; Pharmacogenetics; Prealbumin; Radionuclide Imaging; Radiopharmaceuticals; Valine | 2014 |
Cardiac and peripheral vasomotor autonomic functions in late-onset transthyretin Val30Met familial amyloid polyneuropathy.
Topics: 3-Iodobenzylguanidine; Aged; Amyloid Neuropathies, Familial; Autonomic Nervous System Diseases; Blood Pressure; Female; Heart Diseases; Humans; Male; Methionine; Microscopy, Electron, Transmission; Middle Aged; Mutation; Prealbumin; Radionuclide Imaging; Sural Nerve; Valine; Vasoconstriction | 2017 |